Bridgepoint places contract and permanent professionals responsible for validating, governing, and maintaining enterprise systems in pharmaceutical, biotech, and medical device manufacturing, including the CDMOs and CMOs that serve them.
ERP validation, CSV/CSA, quality systems, change control, and remediation roles for pharmaceutical, biotech, medical device, and CDMO manufacturers.
Every search is scoped against system criticality, validation lifecycle phase, audit history, and regulatory exposure before sourcing begins. A CSV specialist who has carried IQ/OQ/PQ through an SAP S/4HANA upgrade under active FDA scrutiny is a materially different profile from one who has configured systems outside a GxP environment. We identify that difference through structured assessment, not résumé review.
We screen for documentation quality under manufacturing pressure, direct FDA inspection experience including Form 483 observation response, and the operational judgment that comes from working where a deviation has patient safety consequences. The shortlist you receive reflects that standard.
Staff augmentation and direct hire for pharmaceutical, biotech, medical device, and CDMO organizations.
Qualified validation professionals placed for defined timelines, ERP programs, CSV remediation initiatives, and inspection-critical activities at life sciences manufacturers where permanent headcount is not the right fit.
Permanent placement for validation leadership, quality systems ownership, ERP governance, and GxP compliance roles requiring deep life sciences manufacturing regulatory experience and institutional staying power.
"The people your validated life sciences manufacturing systems depend on."
BridgepointEach search is structured around your validated production systems, GxP regulatory posture, system criticality, and audit history. An SAP QM owner at a pharma cGMP site and a CSV specialist at a CDMO are different searches. We scope them accordingly.
Candidates are evaluated on their operational depth in GxP validated systems. We assess documentation quality, direct FDA inspection interaction, and whether experience was gained inside a regulated manufacturing environment or on the periphery of one.
FDA Form 483 observations, pre-approval inspection timelines, and warning letter remediation commitments operate on fixed schedules. We move quickly against those timelines and maintain the screening rigor your compliance posture requires.
We serve manufacturers where validated production systems, GxP compliance, and patient safety are operational requirements, not compliance checkboxes.
Start a conversation about your life sciences manufacturing search. No obligation, complete discretion.